| [February 14, 2012] |
 |
Research and Markets: Sweden In Vitro Diagnostics Market Outlook to 2017
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/5da185/sweden_in_vitro_di)
has announced the addition of GlobalData's new report "Sweden
In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic
Testing, Haematology, Histology And Cytology, Immuno Chemistry,
Infectious Immunology and Microbiology Culture" to their offering.
GlobalData's new report, Sweden
In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic
Testing, Haematology, Histology And Cytology, Immuno Chemistry,
Infectious Immunology and Microbiology Culture provides key market
data on the Sweden In Vitro Diagnostics market. The report provides
value (USD million) data for each segment and sub-segment within seven
market categories - Clinical Chemistry, Genetic Testing, Haematology,
Histology And Cytology, Immuno Chemistry, Infectious Immunology and
Microbiology Culture. The report also provides company shares and
distribution shares data for each of the aforementioned market
categories. The report is supplemented with global corporate-level
profiles of the key market participants with information on company
financials and pipeline products, wherever available.
Scope
-
Market size and company share data for In Vitro Diagnostics market
categories - Clinical Chemistry, Genetic Testing, Haematology,
Histology And Cytology, Immuno Chemistry, Infectious Immunology and
Microbiology Culture.
-
Annualized market revenues (USD million) data for each of the segments
and sub-segments within seven market categories. Data from 2003 to
2010, forecast forward for 7 years to 2017.
-
2010 company shares and distribution shares data for each of the seven
market categories.
-
Global corporate-level profiles of key companies operating within the
Sweden In Vitro Diagnostics market.
Companies Mentioned:
-
F. Hoffmann-La Roche Ltd.
-
Siemens (News - Alert) Healthcare
-
Abbott Laboratories
-
bioMerieux S.A.
-
Ortho-Clinical Diagnostics Inc.
-
Beckman Coulter, Inc.
-
Bio-Rad Laboratories, Inc.
-
Becton, Dickinson and Company
-
Sysmex Corporation
-
DiaSorin S.p.A
-
Phadia AB
-
Qiagen N.V.
-
HORIBA, Ltd.
-
DIAGNOSTICA STAGO, Inc.
-
Gen-Probe Incorporated
-
PerkinElmer, Inc.
-
Thermo Fisher Scientific Inc.
-
Grifols, S.A.
-
Cellestis Limited
-
Hologic, Inc.
-
Immucor, Inc.
-
Danaher Corporation (News - Alert)
-
Life Technologies Corporation
For more information visit http://www.researchandmarkets.com/research/5da185/sweden_in_vitro_di

[ Back To TMCnet.com's Homepage ]
|